Miles O’Brien of the PBS NewsHour reports on how scientists are developing cheaper and more efficient tests for Ebola, highlighting Prof. Lee Gehrke’s simple diagnostic kits. Gehrke explains that the test his team developed is “very simple, requires no refrigeration, no power, no special training.”
Emma Cott of The New York Times writes about Huggable, a robotic teddy bear developed by Professor Cynthia Breazeal and researchers at Boston Children’s Hospital for therapeutic use in pediatric hospitals. “It’s not only the health and emotional and recovery benefits, but also logistical and financial, improving efficiency to the overall health system,” says Breazeal.
Philips is moving its North American research headquarters to Kendall Square and has announced a $25 million research alliance with MIT, reports Boston Globe correspondent Karen Weintraub. MIT and Philips have a “resonance on specific technical issues, but also on the approach to innovation,” says Associate Provost Karen Gleason.
MedTech Boston reporter Jenni Whalen writes that Philips has formed an alliance with MIT and plans to move its North American research headquarters to Cambridge. “By moving to Cambridge and collaborating with MIT, its staff and its partners, Philips can work with some of the best minds in the world,” explains Henk van Houten, executive vice president and general manager of Philips Research.
After the release of a paper from U.C. Berkeley researchers detailing how certain strains of yeast may be used to produce opioids, Professor Kenneth Oye coauthored a commentary calling for regulation in the field, writes Lexi Pandell for Wired. “I haven’t seen anything quite like this before,” says Oye.
Rachel Feltman writes for The Washington Post about a commentary by Professor Kenneth Oye that calls for regulation of genetically modified yeast that could potentially produce opiates. “It’s not like tomorrow someone’s going to have a fully integrated, one-pot pathway to go from sugar to morphine,” says Oye. “But it’s coming.”
Michael Le Page writes for The New Scientist about Professor Kenneth Oye’s commentary on research indicating that genetically engineered yeasts could be used to produce opiates. Oye provides a number of policy recommendations to prevent illicit opium production, including outlawing the distribution of opiate-making yeast strains.
Professor Kenneth Oye has coauthored a commentary on a paper that demonstrates researchers may be close to being able to engineer morphine from yeast, writes Nicola Twilley for The New Yorker. The authors worry this “could put illicit opiate production into the hands of many more people, at a much smaller scale.”
Donald McNeil writes for The New York Times about a commentary coauthored by Professor Kenneth Oye on advances that could make it possible to produce morphine using genetically modified yeast. Oye argues for “locking up the bioengineered yeast strains and restricting access to the DNA that would let drug cartels reproduce them.”
The Associated Press writes about Professor Kenneth Oye’s commentary on a paper by researchers at U.C. Berkeley that shows how morphine and other painkillers can be manufactured without opium poppies. Oye calls for regulation in order to prevent abuses.
“MIT researchers have created an algorithm [that] can distinguish between different lymphomas in real time,” writes Melissa Malamut for Boston Magazine. Graduate student Yuan Luo and Professor Peter Szolovits developed a system that can automatically suggest cancer diagnoses based on data points from past pathology reports, Malamut explains.
Lindsay Kalter writes for The Boston Herald about PicnicHealth, a California-based startup founded by MIT alumnus Troy Astorino that allows patients to store all their medical records in one spot. One day “patients will really have ownership of their own medical info and have it all in one place,” said Astorino.
Boston.com reporter Dialynn Dwyer writes about how graduate student Steven Keating “fought his cancer with curiosity.” Dwyer explains that Keating “gathered his health data in order to understand the science behind what his body was going through” and even filmed his brain surgery.
Mark Shanahan writes for The Boston Globe that the organizers of HUBweek, an innovation-themed festival designed to showcase Boston’s leadership in education, medicine, technology and the arts, gathered at a launch party last week. As part of HUBweek, MIT will host “Solve,” an event designed to bring together leaders in a variety of areas to tackle global challenges.
BetaBoston reporter Nidhi Subbaraman writes about how graduate student Steven Keating's thirst for knowledge may have saved his life. After experiencing phantom odors, Keating urged his doctors to perform a brain scan, which revealed a tumor. Since then, Keating has “open-sourced” his illness, and become a “champion of a movement to provide patients with more information about their health.”